Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: betthepharm who wrote (361)	4/7/1998 7:01:00 PM
From: Greed Is Good	Read Replies (2) \| Respond to of 1510

Does anyone follow the # of analysts that follow IMNR and what their individual ratings are? (The Yahoo research area has 2 strong buys and 2 holds). Have several analysts dropped coverage recently as I thought there were previously 5 or 6?. When an analyst drops coverage, is it then recommended to the clients invested to sell, and could this account for the recent weakness? Thanks to all for your input and technical analysis, I have lots of questions, but few answers on IMNR.